Gefitinib ('Iressa', ZD1839) given in the 'Iressa' Expanded Access Programme in patients with non-small-cell lung cancer

被引：0

|

作者：

Chioni, A

Barbieri, F

Baldini, E

Orlandini, C

Ricci, S

Conte, PF

机构：

[1] Ciari Univ Hosp, Pisa, Italy

[2] Policlin Univ Hosp, Pisa, Italy

来源：

BRITISH JOURNAL OF CANCER | 2003年 / 89卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：S26 / S27

页数：2

相关论文

共 50 条

[1] Gefitinib ('Iressa', ZD1839) for patients with advanced non-small-cell lung cancer treated in the 'Iressa' Expanded Access Programme at a single institution in Brazil
Katz, A
Smaletz, O
Simon, SD
Rene, GC
Hoff, PM
Tabacof, J
BRITISH JOURNAL OF CANCER, 2003, 89 : S29 - S29
[2] Analysis of the efficacy and tolerability of gefitinib ('Iressa', ZD1839) in previously treated patients with non-small-cell lung cancer enrolled in the 'Iressa' Expanded Access Programme
de Leeuw, K
Schallier, D
Sermijn, E
Fontaine, C
Neyns, B
Samijn, I
de Grève, J
BRITISH JOURNAL OF CANCER, 2003, 89 : S28 - S28
[3] Gefitinib ('Iressa', ZD1839) in heavily pretreated non-small-cell lung cancer patients: a case series report from the 'Iressa' Expanded Access Programme
Gridelli, C
Rossi, A
Maione, P
Musto, L
Del Gaizo, F
Airoma, G
BRITISH JOURNAL OF CANCER, 2003, 89 : S29 - S29
[4] Gefitinib ('Iressa', ZD1839) as treatment for non-small-cell lung cancer
Razis, E
Papadopoulos, S
Skarlos, D
Exarchakos, M
Christodoulou, C
Karina, M
Xylouri, M
Labropoulos, S
BRITISH JOURNAL OF CANCER, 2003, 89 : S32 - S32
[5] Gefitinib ('Iressa', ZD1839) in relapsed non-small-cell lung cancer
Reck, M
Gatzemeier, U
BRITISH JOURNAL OF CANCER, 2003, 89 : S32 - S33
[6] Refractory non-small-cell lung cancer: clinical experience with gefitinib ('Iressa', ZD1839) in 28 patients who entered the 'Iressa' Expanded Access Programme at the Sydney Cancer Centre
Boyer, M
BRITISH JOURNAL OF CANCER, 2003, 89 : S26 - S26
[7] Rapid symptom improvement in a patient with non-small-cell lung cancer given gefitinib ('Iressa', ZD1839)
Martínez, JL
BRITISH JOURNAL OF CANCER, 2003, 89 : S30 - S31
[8] Gefitinib ('Iressa', ZD1839) in heavily pretreated patients with metastatic non-small-cell lung cancer
Martín-Algarra, S
Gurpide, A
Lopez-Picazo, JM
BRITISH JOURNAL OF CANCER, 2003, 89 : S30 - S30
[9] Gefitinib ('Iressa', ZD1839) in advanced non-small-cell lung cancer patients progressed to chemotherapy
Cortes-Funes, H
Figueiras, MC
Martín-Algarra, S
Salinas, P
Massutí, B
Gascón, P
Rosell, R
BRITISH JOURNAL OF CANCER, 2003, 89 : S27 - S27
[10] Efficacy of gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer metastatic to the brain
Diaz-Cantón, E
BRITISH JOURNAL OF CANCER, 2003, 89 : S28 - S28

← 1 2 3 4 5 →